Flash Briefing: WBHO shares drop 17%; Levi's to relist; EU to make Brexit concessions; Teva goes for biotech

In today’s global business headlines… With just six weeks to go before Brexit is enacted, the European Union is reportedly preparing to make further concessions. Shares in iconic jeans maker Levi Strauss & Co are set to return to the public markets later this year, more than three decades after delisting. Israeli group Teva Pharmaceutials, the world’s largest maker of generic drugs, is moving into high-price biotech medicines in an attempt to revive its fortunes. In South African related news, the share price of construction group Wilson Bayly Holmes-Ovcon took a 17% knock yesterday after it warned shareholders that 2018’s profits would be virtually wiped out.